Globe Newswire
LISBON, Portugal and HOLMDEL, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global provider of Identity and Access Management (IAM) and biometric authentication solutions, today announced a technology integration with Cipher, Prosegur's specialized cybersecurity division, bringing BIO-key's identity security technologies into Cipher's cybersecurity services and solutions portfolio.
The integration addresses the increasing... (continue reading...)
- Allergen-specific, human-derived IgG4 antibodies prevent allergic reactions by neutralizing allergens and redirecting them toward tolerance-associated immune pathways
- Mechanism-of-action observed across different allergy indications
- Study provides preclinical proof-of-concept for Mabylon’s proprietary allergen-neutralizing approach
Schlieren/Zurich, Switzerland, November 3, 2026 – Mabylon AG, a leader in the discovery and development of human-derived, half-life extended... (continue reading...)
Company announcement no. 44 - 2603 November 2026
Transactions in connection with share buy-back program
On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 3 - 26. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe... (continue reading...)
- Allergen-specific, human-derived IgG4 antibodies prevent allergic reactions by neutralizing allergens and redirecting them toward tolerance-associated immune pathways
- Mechanism-of-action observed across different allergy indications
- Study provides preclinical proof-of-concept for Mabylon’s proprietary allergen-neutralizing approach
Schlieren/Zurich, Switzerland, November 3, 2026 – Mabylon AG, a leader in the discovery and development of human-derived, half-life extended... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s),... (continue reading...)More Globe Newswire
View Older Stories-
Resolutions of the Extraordinary General Meeting of shareholders of Nordic Fibreboard AS
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
UKey's Latest Firmware Passes CertiK Security Audit, With All Findings Remediated
-
UKey's Latest Firmware Passes CertiK Security Audit, With All Findings Remediated
-
Phrasly Launches a Free AI Image Detector as Fake Profile Photos, Listings, and News Images Become the Norm
-
AiMOGA’s Strategic AI Ecosystem Creates New Opportunities for LUXEED’s Intelligent Evolution
-
Global Licensing Group Rebrands as Brand Licensing by Informa: A Bold New Identity for a Booming Industry
-
Faraday Accelerates AI-Driven Manufacturing and Humanoid Robotics with EtherCAT-Compliant Ethernet PHY IP
-
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
-
AB Akola Group plans to invest EUR 52 million in its businesses in 2026/27
-
Third Quarter Report 2026
-
GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12
-
EDF: EDF announces exercise of option to redeem hybrid bonds
-
Solar A/S: No. 14 2026 Q3 EBITDA in line with expectations
-
INQ Group AB (publ) raises SEK 7 million under convertible loan facility from new US-based investment manager
-
Equinor ASA: Share buy-back – fourth tranche for 2026
-
Transaction in Own Shares
-
Progress on share buyback programme
-
AS Tallink Grupp Statistics for October 2026
-
Solar A/S: No. 13 2026 Financial calendar 2027 for Solar
-
STARTRADER Spotlights ANTHUSD Pre-IPO CFD as Anthropic Files to List on Nasdaq
-
Merck KGaA, Darmstadt, Germany, to Divest CDMO Business to Lonza
-
Merck to Divest CDMO Business to Lonza
-
Coloplast A/S - Annual Report 2025/26 & Remuneration Report 2025/26
-
Ultima Markets Strengthens European Community Connections Through Trading and Networking Event
-
New research initiative will utilise AI to optimise Nordic energy grid capacity, improve resilience and prepare for future needs
-
ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
-
Icelandic Salmon - Third quarter 2026 results
-
International Petroleum Corporation Announces Third Quarter 2026 Financial and Operational Results
-
Strong Cresemba® (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea
-
Trifork strengthens its medical software capabilities with MDR certification and CE marking of nationwide medication solution
-
Wereldhave Trading update Q3 2026
-
HII and Thales Successfully Demonstrate Expeditionary PathMaster's Ability to Deliver an End-to-End Autonomous Mine Countermeasure Mission
-
WISeQey Announces Preliminary Nine-Month 2026 Financial Results and Provides Corporate Update
-
Clariant delivers strong local currency sales growth in volatile trading conditions, confirms FY guidance
-
Start of Day Message
-
Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated
-
Invitation to Idorsia's webcast and conference call to provide more context on the opportunity and launch approach for TRYVIO/JERAYGO
-
HII and Thales Successfully Demonstrate Expeditionary PathMaster's Ability to Deliver an End-to-End Autonomous Mine Countermeasure Mission
-
argenx to Present at Upcoming Investor Conferences
-
Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands
-
Central Bank of Savings Banks Finland Plc, Sp Mortgage Bank Plc & Savings Banks Group: Release of Financial Statements for 2026 will be published on 11th of February 2027
-
RUBIS: Q3 & 9M Trading update - Another quarter of strong operational performance - 2026 Guidance reaffirmed
-
Toobit Introduces Scaled Orders for Futures Traders
-
Wood Mackenzie: Middle East conflict reshapes growth, resilience and partnerships across the region's largest NOCs
-
Wood Mackenzie: Middle East conflict reshapes growth, resilience and partnerships across the region's largest NOCs
-
SalMar – Record-high harvest volume and significant improvement in results
-
Cogent Security Makes the Fortune Cyber 60 for a Second Year, With a Plan to Run Cyber Defense Like a Factory
-
Open‑Source, Digital Governance in Spotlight as World Internet Conference Wuzhen Summit Kicks Off
-
Grewal Orthopedic & Spine Care to Open New Huntington Office in January 2027, Expanding Orthopedic, Spine and Physical Therapy Services
